Literature DB >> 11162118

The scFv fragment of the antibody hu4D5-8: evidence for early premature domain interaction in refolding.

M Jäger1, P Gehrig, A Plückthun.   

Abstract

Fluorescence spectroscopy and 1H/2H-exchange techniques have been applied to characterize the folding of an scFv fragment, derived from the humanized anti-HER2 antibody hu4D5-8. A stable intermediate, consisting of a native VL domain and an unfolded VH domain, is populated under equilibrium unfolding conditions. A partially structured intermediate, with 1H/2H-exchange protection significantly less than that of the two isolated domains together, is detectable upon refolding the equilibrium-denatured scFv fragment. This means that the domains in the heterodimer do not fold independently. Rather, they associate prematurely before full 1H/2H-exchange protection can be gained. The formation of the native heterodimer from the non-native intermediate is a slow, cooperative process, which is rate-limited by proline cis/trans-isomerization. Unproductive domain association is also detectable after short-term denaturation, i.e. with the proline residues in native conformation. Only a fraction of the short-term denatured protein folds into the native protein in a fast, proline-independent reaction, because of spontaneous proline cis/trans-reisomerization in the early non-native intermediate. The comparison with the previously studied antibody McPC603 has now allowed us to delineate similarities in the refolding pathway of scFv fragments.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162118     DOI: 10.1006/jmbi.2000.4342

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  10 in total

1.  Expression of high-affinity human antibody fragments in bacteria.

Authors:  Romain Rouet; David Lowe; Kip Dudgeon; Brendan Roome; Peter Schofield; David Langley; John Andrews; Peter Whitfeld; Lutz Jermutus; Daniel Christ
Journal:  Nat Protoc       Date:  2012-02-02       Impact factor: 13.491

2.  Distinguishing specific and nonspecific interdomain interactions in multidomain proteins.

Authors:  Lucy G Randles; Sarah Batey; Annette Steward; Jane Clarke
Journal:  Biophys J       Date:  2007-09-21       Impact factor: 4.033

3.  A scFv antibody mutant isolated in a genetic screen for improved export via the twin arginine transporter pathway exhibits faster folding.

Authors:  Brian Ribnicky; Thomas Van Blarcom; George Georgiou
Journal:  J Mol Biol       Date:  2007-03-31       Impact factor: 5.469

4.  DARPins: an efficient targeting domain for lentiviral vectors.

Authors:  Robert C Münch; Michael D Mühlebach; Thomas Schaser; Sabrina Kneissl; Christian Jost; Andreas Plückthun; Klaus Cichutek; Christian J Buchholz
Journal:  Mol Ther       Date:  2011-01-11       Impact factor: 11.454

5.  Asymmetric effect of domain interactions on the kinetics of folding in yeast phosphoglycerate kinase.

Authors:  Szabolcs Osváth; Gottfried Köhler; Péter Závodszky; Judit Fidy
Journal:  Protein Sci       Date:  2005-05-09       Impact factor: 6.725

6.  Apparent cooperativity in the folding of multidomain proteins depends on the relative rates of folding of the constituent domains.

Authors:  Sarah Batey; Jane Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-15       Impact factor: 11.205

7.  Expression of recombinant multi-coloured fluorescent antibodies in gor -/trxB- E. coli cytoplasm.

Authors:  Anatoliy Markiv; Richard Beatson; Joy Burchell; Ravi V Durvasula; Angray S Kang
Journal:  BMC Biotechnol       Date:  2011-11-30       Impact factor: 2.563

Review 8.  Intramolecular immunological signal hypothesis revived--structural background of signalling revealed by using Congo Red as a specific tool.

Authors:  A Jagusiak; L Konieczny; M Krol; P Marszalek; B Piekarska; P Piwowar; I Roterman; J Rybarska; B Stopa; G Zemanek
Journal:  Mini Rev Med Chem       Date:  2015       Impact factor: 3.862

9.  The folding pathway of a single domain in a multidomain protein is not affected by its neighbouring domain.

Authors:  Sarah Batey; Jane Clarke
Journal:  J Mol Biol       Date:  2008-02-29       Impact factor: 5.469

10.  Rapid optimization and prototyping for therapeutic antibody-like molecules.

Authors:  Lihui Xu; Neeraj Kohli; Rachel Rennard; Yang Jiao; Maja Razlog; Kathy Zhang; Jason Baum; Bryan Johnson; Jian Tang; Birgit Schoeberl; Jonathan Fitzgerald; Ulrik Nielsen; Alexey A Lugovskoy
Journal:  MAbs       Date:  2013-02-07       Impact factor: 5.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.